Type 1 Diabetes is associated with a significant, on-going health care burden for the individual and the community.  While insulin pump therapy will tailor the insulin dose and delivery accordingly, insulin dosing for carbohydrate, fat and protein is significantly more complicated than determining the insulin dose for carbohydrate alone.

This is particularly challenging in insulin pump therapy where decisions are made by families on a daily basis regarding the dose, split and duration of delivery of the insulin for their child.  Using a tool to translate study findings into daily practice will be highly beneficial for families.

Previous studies have demonstrated that smartphone applications can reduce insulin dose errors, support self-management and improve glycaemic control.  An insulin dosing application is the ideal tool to guide complicated adjustments for children and young people.

We will be conducting a randomised control trial using OptimAAPP to optimise dosing for fat, protein and carbohydrate in children and adolescents using insulin pump therapy.  We have been contacted by people from all over Australia keen to participate in the immune pump therapy arm of the study."

 

Researchers 
Research Area 
Project type 
Project Grant
Year of funding 
2019